This is a routine governance filing with no immediate financial impact. Monitor the next quarterly report for any changes in audit findings or financial reporting quality under KPMG. The renewed share issuance and buyback authorizations are standard and do not signal imminent capital actions.
Price Chart
Executive Summary
Pharming Group N.V. filed a 6-K reporting the results of its 2026 Annual General Meeting of Shareholders, where shareholders approved all proposals including the appointment of KPMG Accountants N.V. as the new external auditor for 2026-2028, replacing Deloitte. The filing also notes the renewal of authorizations for the Board to issue and repurchase shares. No financial results or material operational updates were disclosed.
Key Facts
- Shareholders approved all AGM proposals on May 28, 2026.
- KPMG Accountants N.V. appointed as external auditor for fiscal years 2026-2028, replacing Deloitte.
- Deloitte's reports for 2024 and 2025 contained no adverse opinion or disclaimer of opinion.
- No disagreements or reportable events occurred between the company and Deloitte during the relevant periods, except for previously disclosed material weaknesses in internal control over financial reporting.
- Authorizations for the Board to issue shares and repurchase shares were renewed.
- Remuneration policy for Non-Executive Directors' fees was amended.
Financial Impact
No financial figures disclosed in the filing.
Risk Factors
- Auditor change may lead to adjustments in financial reporting processes or internal controls.
- Previously disclosed material weaknesses in internal control over financial reporting remain unresolved.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001828316-26-000029 |
| Document: 0001828316-26-000029-index-headers.html | 0001828316-26-000029 |
| Document: 0001828316-26-000029-index.html | 0001828316-26-000029 |
| Document: 0001828316-26-000029.txt | 0001828316-26-000029 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | 6-K | $11.21 $10.55 | ▼ −5.89% | ▼ −5.67% | $9.75 (−13.02%) |
Aug 13, 2026 7w ago | 6-K | $12.35 $11.68 | ▼ −5.43% | ▼ −3.46% | $9.75 (−21.05%) |
Jun 4, 2026 17w ago | 6-K | $12.47 $12.88 | ▲ +3.29% | ▲ +5.84% | $9.75 (−21.81%) |
May 28, 2026 18w ago | 6-K | $13.66 $12.24 | ▼ −10.40% | ▼ −10.35% | $9.75 (−28.62%) |
May 22, 2026 19w ago | 6-K | $13.62 $12.28 | ▼ −9.84% | ▼ −11.05% | $9.75 (−28.41%) |
Apr 16, 2026 24w ago | 6-K | $17.33 $16.64 | ▼ −3.98% | ▼ −4.97% | $9.75 (−43.74%) |
Mar 27, 2026 27w ago | 6-K | $16.31 $16.50 | ▲ +1.16% | ▼ −2.70% | $9.75 (−40.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access